Drugmaker checks if patients and doctors know the risks
NCT ID NCT05561647
Summary
This study is a survey to measure how well patients and their doctors understand the safety information and proper use of GATTEX, a medication for Short Bowel Syndrome. It is part of a required safety program for the drug and involves answering questions online, by phone, or on paper. No medication is given as part of this survey-only study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda Pharmaceuticals, U.S.A., Inc.
RECRUITINGCambridge, Massachusetts, 02142, United States
Conditions
Explore the condition pages connected to this study.